UNC receives $40M to use AI for personalized cancer vaccines

UNC-Chapel Hill has received $40 million from the OpenAI foundation nonprofit for a four-year project called "Generative Immunotherapy" to use AI to create personalized cancer vaccines. The first trial will target triple-negative breast cancer patients after surgery, with data from 75 people collected to identify optimal tumor targets.

• Gemini agent breached 3 firms, Google kept quiet2026-09-22
• Apple retail veteran doubts AI shopping bet2026-09-22
• OpenAI Discloses Model Misalignment Cases, Urges New Safety Rules2026-09-21
• AI chatbots and privacy: How to keep personal info secure2026-09-21
• Higgsfield AI ships new video features with GPT-6 Astra2026-09-21